India Globalization Capital, Inc. Share Price Nyse
Equities
US45408X1000
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 1.24M 97.19M | Sales 2025 * | 1.4M 109M | Capitalization | 32.62M 2.55B |
---|---|---|---|---|---|
Net income 2024 * | -12M -938M | Net income 2025 * | -10M -782M | EV / Sales 2024 * | 26.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 23.3 x |
P/E ratio 2024 * |
-1.97
x | P/E ratio 2025 * |
-2.71
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.56% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 28/04/05 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 08/05/18 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 28/04/05 |
Richard Prins
CHM | Chairman | 67 | 30/04/07 |
Director/Board Member | 79 | 17/01/22 |
1st Jan change | Capi. | |
---|---|---|
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |